SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CAMPO, Gianluca Calogero
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.740
EU - Europa 3.571
AS - Asia 3.331
OC - Oceania 28
AF - Africa 21
SA - Sud America 18
Continente sconosciuto - Info sul continente non disponibili 6
Totale 22.715
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.716
CN - Cina 1.407
IT - Italia 1.034
SG - Singapore 878
UA - Ucraina 611
TR - Turchia 481
DE - Germania 479
GB - Regno Unito 354
PL - Polonia 294
ID - Indonesia 289
SE - Svezia 278
FI - Finlandia 185
FR - Francia 132
HK - Hong Kong 56
IN - India 52
BE - Belgio 50
VN - Vietnam 44
CZ - Repubblica Ceca 32
AU - Australia 25
KR - Corea 23
CA - Canada 22
JP - Giappone 21
ES - Italia 17
EG - Egitto 16
IR - Iran 15
RU - Federazione Russa 15
NL - Olanda 13
MY - Malesia 11
PK - Pakistan 11
CH - Svizzera 10
DK - Danimarca 10
TH - Thailandia 10
IE - Irlanda 8
RO - Romania 8
TW - Taiwan 8
IQ - Iraq 7
BR - Brasile 6
CO - Colombia 6
CY - Cipro 5
MK - Macedonia 5
PT - Portogallo 5
RS - Serbia 5
EU - Europa 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
CL - Cile 3
HR - Croazia 3
KE - Kenya 3
LI - Liechtenstein 3
NZ - Nuova Zelanda 3
BQ - ???statistics.table.value.countryCode.BQ??? 2
GR - Grecia 2
HU - Ungheria 2
IL - Israele 2
LT - Lituania 2
MX - Messico 2
NO - Norvegia 2
PH - Filippine 2
PS - Palestinian Territory 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
AR - Argentina 1
BD - Bangladesh 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
IM - Isola di Man 1
KW - Kuwait 1
LU - Lussemburgo 1
MD - Moldavia 1
SA - Arabia Saudita 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 22.715
Salva come PNG Salva come JPEG
Città #
Fairfield 2.306
Woodbridge 1.817
Ashburn 1.309
Houston 1.176
Chandler 1.034
Seattle 944
Wilmington 851
Ann Arbor 809
Cambridge 767
Jacksonville 758
Singapore 654
Izmir 339
Beijing 327
Princeton 325
Warsaw 285
Jakarta 273
Nanjing 268
New York 259
Shanghai 249
Ferrara 218
San Diego 206
Milan 180
Boardman 134
Los Angeles 107
Santa Clara 98
Bremen 80
Shenyang 74
Nanchang 72
Bologna 67
Redwood City 64
Falls Church 63
Jiaxing 52
Tianjin 50
Washington 49
Brussels 48
Mountain View 44
Munich 44
Helsinki 42
Hong Kong 42
London 42
Changsha 40
Hebei 40
Dong Ket 39
Addison 34
San Mateo 34
Norwalk 32
Jinan 26
Lappeenranta 26
Brno 24
Chicago 24
Des Moines 23
Kunming 23
Orange 22
Augusta 21
Ningbo 20
Redmond 20
Rome 17
Zhengzhou 17
Tappahannock 16
Auburn Hills 15
Dearborn 15
Taizhou 13
Guangzhou 12
Hangzhou 12
Leawood 12
Melbourne 12
Monmouth Junction 12
Napoli 12
Rimini 12
Tokyo 12
Mumbai 11
Amsterdam 10
Frankfurt am Main 10
Hounslow 10
Indiana 10
Kilburn 10
Lugo 9
Bangkok 8
Chennai 8
Ferrara di Monte Baldo 8
Lanzhou 8
Treviso 8
Ardabil 7
Arezzo 7
Changchun 7
Dublin 7
Montreal 7
Naples 7
Olomouc 7
Parma 7
Cairo 6
Florence 6
Genoa 6
Imola 6
Odense 6
Padova 6
Paris 6
Perth 6
Phoenix 6
Poggio Renatico 6
Totale 17.389
Salva come PNG Salva come JPEG
Nome #
Physical activity intervention for elderly patients with reduced physical performance after acute coronary syndrome (HULK study): Rationale and design of a randomized clinical trial 259
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease 187
Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology 181
Mitochondrial permeability transition involves dissociation of F1FO ATP synthase dimers and C-ring conformation 159
Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings 159
Exercise Intervention to Improve Functional Capacity in Older Adults After Acute Coronary Syndrome 156
Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury 155
The use of nutraceuticals to counteract atherosclerosis: The role of the Notch pathway 145
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 144
Kounis-Zavras syndrome presenting with ventricular arrhythmias and cardiogenic shock 143
Translating Evidence from Clonal Hematopoiesis to Cardiovascular Disease: A Systematic Review 142
The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program: rational and design of a multicenter prospective study 139
Tissue factor and coagulation factor VII levels during acute myocardial infarction: association with genotype and adverse events. 138
Poor response to clopidogrel: current and future options for its management 138
Prospective identification of stent fracture by enhanced stent visualization system during percutaneous coronary intervention 137
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 135
Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial 135
Short Physical Performance Battery and all-cause mortality: Systematic review and meta-analysis 134
Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial 134
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 134
Notch Signaling Regulates Immune Responses in Atherosclerosis 134
SERPINA1 Gene Promoter Is Differentially Methylated in Peripheral Blood Mononuclear Cells of Pregnant Women 133
Fractional flow reserve: Current applications and overview of the available data 132
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 131
Medical and interventional management of patients with severe thrombocytopenia undergoing percutaneous coronary intervention 130
Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis 130
Discovery of Novel 1,3,8-Triazaspiro[4.5]decane Derivatives That Target the c Subunit of F1/FO-Adenosine Triphosphate (ATP) Synthase for the Treatment of Reperfusion Damage in Myocardial Infarction 129
Fractional flow reserve evaluation and chronic kidney disease: Analysis from a multicenter Italian registry (the FREAK study) 128
Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial 128
Prognostic Impact of Hospital Readmissions After Primary Percutaneous Coronary Intervention 127
Tailored Medical and Interventional Therapy Against Recurrent Stent Thrombosis After Drug-Eluting Stenting 126
Reperfusion Damage - A Story of Success, Failure, and Hope 126
Can we improve myocardial protection during ischaemic injury? 126
Mechanistic role of mPTP in ischemia-reperfusion injury 125
Randomized, double-blind comparison of effects of abiciximab bolus only vs. on-label regimen on ex vivo inhibition of platelet aggregation in responders to clopidogrel undergoing coronary stenting 123
In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome 123
Bioresorbable Scaffold vs. Second Generation Drug Eluting Stent in Long Coronary Lesions requiring Overlap: A Propensity-Matched Comparison (the UNDERDOGS study) 123
The in vitro effects of verbascoside on human platelet aggregation 121
Ticagrelor improves endothelial function by decreasing circulating Epidermal Growth Factor (EGF) 121
A Patient-Level Pooled Analysis Assessing the Impact of the SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) Score on 1-Year Clinical Outcomes in 6,508 Patients Enrolled in Contemporary Coronary Stent Trials 121
Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis 120
A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial 119
The Mitochondrial Permeability Transition Pore 117
Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention 117
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes 116
Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials 116
Characterization of Dermal Stem Cells of Diabetic Patients 116
Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study trial 116
Short-versus long-term duration of dual-antiplatelet therapy after coronary stenting: A randomized multicenter trial 115
Impact of a recent hospitalization on treatment and prognosis of ST-segment elevation myocardial infarction 115
Grip strength predicts cardiac adverse events in patients with cardiac disorders: An individual patient pooled meta-analysis 115
The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary syndrome 115
Relationship between Troponin Elevation, Cardiovascular History and Adverse Events in Patients with acute exacerbation of COPD 114
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 113
Impact of COPD on Long-term Outcome After ST-Segment Elevation Myocardial Infarction Receiving Primary Percutaneous Coronary Intervention 113
Patient selection to enhance the long-term benefit of first generation drug-eluting stents for coronary revascularisation procedures. Insights from a large multicentre registry 113
A Strategy to offset the extra cost of sirolimus-eluting stent in patients undergoing intervention for acute myocardial infarction. 111
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: Results from the double-blind, prospective, randomized tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel study 111
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes (Am Journal of Cardiovasc Drugs (2011) 11:3 (189-98)) 111
Relevance of gender in patients with acute myocardial infarction undergoing coronary interventions 111
Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates 111
Effectiveness and safety of the ABSORB bioresorbable vascular scaffold for the treatment of coronary artery disease: Systematic review and meta-analysis of randomized clinical trials 111
C subunit of F1/FO-ATP synthase as target for preventing the detrimental effect of myocardial ischemia/reperfusion injury 111
High-dose BoluS TiRofibAn and Sirolimus eluting STEnt versus abiciximab and bare metal stent in acute MYocardial infarction (STRATEGY) study - Protocol design and demography of the first 100 patients 110
Quantitative Flow Ratio Identifies Nonculprit Coronary Lesions Requiring Revascularization in Patients with ST-Segment-Elevation Myocardial Infarction and Multivessel Disease 110
Meta-Analysis of the Duration of Dual Antiplatelet Therapy in Patients Treated with Second-Generation Drug-Eluting Stents 109
CHA2DS2-VASc risk factors as predictors of stroke after acute coronary syndrome: A systematic review and meta-analysis 109
Specific properties and effect of perindopril in controlling the renin-angiotensin system. 108
Relationship between paraoxonase Q192R gene polymorphism and on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention 108
Tissue Factor and Coagulation Factor VII Levels during Acute Myocardial Infarction Contribute to Predict Mortality and re-infarction. 107
Randomized comparison of Zotarolimus-Eluting Endeavor Sprint versus bare-metal stent implantation in uncertain drug-eluting stent candidates: Rationale, design, and characterization of the patient population for the Zotarolimus-eluting Endeavor Sprint stent in Uncertain DES Candidates study 107
Poor responsiveness to clopidogrel. Drug-specific or class-effect? 107
Antithrombotic management and 1-year outcome of patients on oral anticoagulation undergoing coronary stent implantation (from the registro regionale angioplastiche Emilia-Romagna registry) 107
Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registry 107
Coagulation factors and recurrence of ischemic and bleeding adverse events in patients with acute coronary syndromes 106
Fractional flow reserve implementation in daily clinical practice: A European survey 106
Operator, Drug or Device: Who Will Break Down Acute Stent Thrombosis 106
Nutritional status and all-cause mortality in older adults with acute coronary syndrome 106
Bleeding Risk Scores and Scales of Frailty for the Prediction of Haemorrhagic Events in Older Adults with Acute Coronary Syndrome: Insights from the FRASER study 106
Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study 105
Long-term outcomes with cobalt-chromium bare-metal vs. drug-eluting stents: the REgistro regionale AngiopLastiche dell'Emilia-Romagna registry 105
Context-dependent function of ROS in the vascular endothelium: The role of the Notch pathway and shear stress 104
Long-term clinical outcomes and cost-effectiveness analysis in multivessel percutaneous coronary interventions: comparison of drug-eluting stents, bare-metal stents and a mixed approach in patients at high and low risk of repeat revascularisation. 103
Different clinical models of CD34 plus cells mobilization in patients with cardiovascular disease 103
Diagnostic performance of in-procedure angiography-derived quantitative flow reserve compared to pressure-derived fractional flow reserve: The FAVOR II Europe-Japan study 102
Role of the tricuspid regurgitation after mitraclip and transcatheter aortic valve implantation: A systematic review and meta-analysis 102
New and old strategies to afford the liberal use of drug-eluting stents in real-life scenarios 101
Same-day transfer for the invasive strategy of patients with non-ST-segment elevation acute coronary syndrome admitted to spoke hospitals: Data from the Emilia-Romagna Regional Network 101
A Prospective Evaluation of a Standardized Strategy for the Use of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in ST-Segment Elevation Myocardial Infarction: Rationale and Design of the BVS STEMI STRATEGY-IT Study 101
Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials. 100
Dual Antiplatelet Therapy in Patients with Glucose-6-Phosphate Dehydrogenase Deficiency undergoing PCI with Drug-Eluting Stents. 100
Incidence and outcome of high on-treatment platelet reactivity in patients with non-st elevation acute coronary syndromes undergoing percutaneous coronary intervention (from the VIP [verifynow and inhibition of platelet reactivity] study) 100
Comparison of Verapamil versus Heparin as Adjunctive Treatment for Transradial Coronary Procedures: The VERMUT Study 100
Specific and selective I-f inhibition: expected clinical benefits from pure heart rate reduction in coronary patients 99
Optical coherence tomography evaluation of overlapping everolimus-eluting bioresorbable vascular scaffold implantation guided by enhanced stent visualization system 99
Coronary artery surgery versus percutaneous coronary intervention in octogenarians: long-term results 98
Impact of culprit plaque and atherothrombotic components on incomplete stent apposition in patients with ST-elevation myocardial infarction treated with Everolimus-eluting stents-an OCTAVIA Substudy 98
Tissue factor and coagulation factor VII levels during AMI: association with genotype and adverse events 96
The impact of the 3-year ABSORB II trial results on my clinical practice: An Italian survey 96
BRS implantation in long lesions requiring device overlapping: Myth or reality? 95
Totale 12.045
Salva come PNG Salva come JPEG
Categoria #
all - tutte 146.247
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.173
Totale 147.420
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.918 0 0 187 666 342 553 473 474 433 435 225 130
2020/20213.841 198 262 194 489 231 300 166 498 174 541 536 252
2021/20223.161 274 287 207 148 146 163 193 195 142 239 337 830
2022/20232.784 340 126 141 235 406 396 177 251 360 71 191 90
2023/20242.794 169 292 130 91 214 490 132 281 68 128 142 657
2024/20251.538 313 330 895 0 0 0 0 0 0 0 0 0
Totale 23.614